Ensysce Biosciences (ENSC) Non-Current Deffered Revenue (2017 - 2021)
Ensysce Biosciences (ENSC) posted Non-Current Deffered Revenue of $2 million for Q1 2021, down 71.4% from $7 million a year earlier and down 70.4% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Non-Current Deffered Revenue (2017 - 2021) Analysis & Trends
At the end of FY2020, Ensysce Biosciences' Non-Current Deffered Revenue came in at $6.75 million, down 3.6% from FY2019.
- Annual Non-Current Deffered Revenue shows a three-year compound annual growth rate of -1.2% (FY2017 to FY2020).
- In prior years, Ensysce Biosciences' Non-Current Deffered Revenue was $7 million in FY2019 (unchanged), $7 million in FY2018 (unchanged) and $7 million in FY2017.
- The Q1 2021 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2017.
- Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 0.0% (Q3 2020) to 71.4% (Q1 2021).
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $6.75 million (Q4 2020), $7 million (Q3 2020) and $7 million (Q2 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Ensysce Biosciences | 1.30 Mn | -10.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | 6.75 Mn |
| Sep 30, 2020 | 7.00 Mn |
| Jun 30, 2020 | 7.00 Mn |
| Mar 31, 2020 | 7.00 Mn |
| Dec 31, 2019 | 7.00 Mn |
| Sep 30, 2019 | 7.00 Mn |
| Jun 30, 2019 | 7.00 Mn |
| Mar 31, 2019 | 7.00 Mn |
| Dec 31, 2018 | 7.00 Mn |
| Sep 30, 2018 | 7.00 Mn |
| Jun 30, 2018 | 7.00 Mn |
| Mar 31, 2018 | 7.00 Mn |
| Dec 31, 2017 | 7.00 Mn |
API Access
Ensysce Biosciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();